CD8A and neoplasm: We demonstrate that blockade of PD-1/PD-L1 impaired inactivation of CD8+ Tcm-phenotype cells adoptively transferred into a strongly tolerogenic environment, promoted effector differentiation and positively impacted the effectiveness of Tcm-phenotype CD8+-mediated adoptive tumour immunotherapy.